The Technical Analyst
Protagenic Therapeutics, [PTIX]
Exchange: PNK Industry: Biotechnology
Protagenic Therapeutics, Price, Forecast, Insider, Ratings, Fundamentals & Signals
3.08% $1.340
America/New_York / 3 mai 2024 @ 09:30
Protagenic Therapeutics, PE Comparison
Report updated: 2024-05-03 @ 11:04| Comp | Ticker | PE |
|---|---|---|
| Arch Therapeutics, Inc. | ARTH | -240.000 |
| Inhibitor Therapeutics, | INTI | -87.900 |
| Artemis Therapeutics Inc. | ATMS | -48.080 |
| Nascent Biotech, Inc. | NBIO | -34.750 |
| AngioSoma, Inc. | SOAN | -22.780 |
| ACRO BIOMEDICAL CO LTD | ACBM | -22.170 |
| Vitality Biopharma, Inc. | VBIO | -15.600 |
| RegeneRx | RGRX | -12.500 |
| Northwest | NWBO | -11.500 |
| Biostage, Inc. | BSTG | -7.310 |
| Enzon Pharmaceuticals, | ENZN | -6.840 |
| Therapeutic Solutions | TSOI | -6.100 |
| Qrons Inc. | QRON | -6.060 |
| International Stem Cell | ISCO | -5.230 |
| HST Global, Inc. | HSTC | -4.290 |
| Burzynski Research | BZYR | -4.000 |
| Nutriband Inc. | NTRB | -3.990 |
| IntelGenx Technologies | IGXT | -3.590 |
| ProtoKinetix, | PKTX | -3.280 |
| ZIVO Bioscience, Inc. | ZIVO | -3.060 |
| Organicell Regenerative | BPSR | -2.400 |
| Agentix Corp. | AGTX | -2.350 |
| Marizyme, Inc. | MRZM | -2.320 |
| Protagenic Therapeutics, | PTIX | -2.110 |
| Cell Source, Inc. | CLCS | -2.050 |
| American CryoStem | CRYO | -1.690 |
| Mymetics Corporation | MYMX | -1.470 |
| Innovation | IPIX | -1.170 |
| AMERICAN BRIVISION | ABVC | -1.130 |
| CytoDyn Inc. | CYDY | -1.110 |
| RenovaCare, Inc. | RCAR | -0.920 |
| RepliCel Life Sciences | REPCF | -0.860 |
| GT Biopharma, Inc. | GTBP | -0.830 |
| Adhera Therapeutics, Inc. | ATRX | -0.820 |
| NovAccess Global Inc. | XSNX | -0.680 |
| GeneThera, Inc. | GTHR | -0.440 |
| Endonovo Therapeutics, | ENDV | -0.390 |
| AXIM Biotechnologies, | AXIM | -0.210 |
| Todos Medical Ltd. | TOMDF | -0.210 |
| Creative Medical | CELZ | -0.190 |
| Cannabics Pharmaceuticals | CNBX | -0.190 |
| Q BioMed Inc. | QBIO | -0.030 |
| Medicure Inc. | MCUJF | 3.950 |
| PharmaCyte Biotech, Inc. | PMCB | 9.390 |
| Immune Therapeutics, Inc. | IMUN | 16.180 |